AlphaGen
Access AlphaGen
Company Narratives

Barkat Frisian Agro Q3 FY2026: Expansion Meets a Margin and Cash-Conversion Test

BFAGRO kept sales growing in 9MFY26, but margin compression and weaker cash conversion made the new capacity ramp the key next-cycle test.

Sep 19, 2026

Company Name: Barkat Frisian Agro Limited

Ticker: BFAGRO

Reporting period: nine months ended 31 March 2026, including the three months ended 31 March 2026. Primary analytical basis: Barkat Frisian Agro Limited’s company-level unaudited condensed interim financial statements prepared under IAS 34. The statement of financial position compares 31 March 2026 with audited 30 June 2025 balances; the profit-and-loss and cash-flow comparatives are unaudited. No independent review report is included in the quarterly package.

Verdict

Barkat Frisian Agro grew sales, but FY2026’s first nine months were a weaker earnings-conversion period than the top line suggests. Revenue increased 5.9% to Rs5.944 billion, yet gross profit was essentially flat and operating profit fell 12.6% to Rs514.7 million. Profit after tax declined a more modest 6.1% to Rs474.6 million because finance costs fell sharply, partially offsetting weaker operating economics.

The quarter itself was more stable at the bottom line but still showed margin pressure. Q3 sales rose 7.4% year on year to Rs1.957 billion, while gross profit fell 2.3% and operating profit slipped 1.2%. PAT edged up 1.0% to Rs174.5 million because finance cost fell 32.7% and other income increased from a low comparable base. The economic message is therefore not simply profit growth: stronger sales are still being converted into less gross and operating profit per rupee of revenue, while lower financing costs are cushioning the result.

Management attributes the nine-month gross-margin decline to weaker exports and higher-than-expected local egg prices in Q1 and Q2, while it says freight costs, expansion-related staffing and site costs and prior-year one-off income also weighed on the comparison. Those are management explanations. The public accounts independently confirm the direction of the margin and expense changes, but do not disclose quarterly egg procurement prices or a quantified bridge for each driver.

Results at a glance

  • Nine-month net sales increased 5.9% to Rs5.944 billion from Rs5.613 billion. Local sales rose 7.1% to Rs5.029 billion, while export sales slipped 0.3% to Rs914.2 million.
  • Nine-month gross profit increased only 0.5% to Rs703.8 million. Gross margin fell to 11.84% from 12.48%, a decline of about 64 basis points.
  • Operating profit declined 12.6% to Rs514.7 million and operating margin fell to 8.66% from 10.49%. Selling and distribution expense rose 15.4%, while administrative expense rose 28.5%.
  • Finance cost fell 55.2% to Rs36.9 million, providing the main below-operating-line offset to weaker operating profit.
  • Nine-month PAT fell 6.1% to Rs474.6 million. Reported EPS fell to Rs1.53 from Rs3.41, but the EPS decline is heavily affected by the IPO-driven increase in weighted-average shares to about 310.0 million from 148.3 million.
  • Q3 sales rose 7.4% to Rs1.957 billion, gross profit fell 2.3% to Rs255.2 million, operating profit fell 1.2% to Rs189.7 million and PAT rose 1.0% to Rs174.5 million.
  • Nine-month net cash generated from operating activities fell 82.5% to Rs73.9 million from Rs422.4 million. Inventory, receivables and lower trade payables all absorbed cash.
  • Capital expenditure surged to Rs915.2 million from Rs73.3 million as the company expanded capacity. Short-term investments were reduced sharply and short-term borrowings increased, helping fund the investment cycle.

AlphaGen model readings

  • Alpha QoQ Score: 39.89
  • TTM Performance Score: 64.01
  • 3Y Business Perf Score: 82.24
  • Sector Leadership Score: 52.66

These four readings are AlphaGen model outputs, not company-reported figures.

What improved

The top line continued to grow, and the growth was domestic rather than export-led. Local sales increased by roughly Rs333 million over the nine-month period, more than offsetting the small decline in export sales. That matters because the domestic business is carrying more of the incremental revenue burden while export sales are temporarily flat.

Q3 PAT was slightly above the prior-year quarter despite weaker gross profit. The explanation is primarily below the operating line: Q3 finance costs fell to Rs12.6 million from Rs18.7 million, while other income rose to Rs11.8 million from Rs6.5 million. This helped profit before tax rise 2.2% even though operating profit was slightly lower.

The financing benefit is material. Over nine months, finance cost fell by about Rs45.4 million, more than the roughly Rs30.7 million decline in PAT. The macro backdrop supports the direction: SBP kept the policy rate at 10.5% through its 9 March 2026 meeting, below rates prevailing through much of the prior comparable period. This does not mean all BFAGRO funding repriced immediately, but it is consistent with a lower interest burden.

Expansion execution also advanced substantially. The March IPO progress report shows Rs813.3 million of Rs880.6 million allocated project funds utilized, or 92.36%. It says core egg-processing equipment had been installed and commissioned and production at the Faisalabad facility was expected to begin in April 2026. The directors’ report dated 29 April subsequently describes the facility as successfully commissioned and operational.

What weakened / needs attention

The central weakness is gross-margin compression. Nine-month cost of sales rose 6.7%, faster than the 5.9% sales increase. Gross profit therefore grew only 0.5%, and gross margin fell by 64 basis points. In Q3, sales rose 7.4% but cost of sales rose about 9.0%, causing gross profit to fall 2.3% and gross margin to decline to 13.04% from 14.34%, a drop of about 130 basis points.

Management links the nine-month gross-margin pressure to weaker exports and higher-than-expected local egg prices in Q1 and Q2. That is economically plausible for a pasteurized-egg processor, but the filing does not publish procurement prices or volume/mix data needed to independently attribute a precise amount. PBS data show urban consumer egg prices fell 17.98% month on month in March 2026, consistent with management’s description of a softer egg market later in the period; it does not establish BFAGRO’s realized raw-material cost.

Operating expenses magnified the gross-margin pressure. Selling and distribution costs rose to Rs140.6 million from Rs121.8 million and administrative costs to Rs67.9 million from Rs52.8 million. Management points to higher freight costs, fresh hiring and added site costs as the company expands. These may be investments ahead of capacity growth, but until new facilities scale they reduce operating leverage. Operating margin fell by about 183 basis points over nine months.

The result also benefited from a much easier finance-cost comparison, so underlying operating progress should not be judged from PAT alone. Operating profit fell by Rs74.0 million, but finance costs improved by Rs45.4 million. A stronger recurring earnings profile requires better gross-margin conversion rather than relying mainly on financing relief.

Recurring versus exceptional earnings

The current nine-month result does not appear to be dominated by a single exceptional gain. Exchange gain was Rs10.3 million and other income Rs50.7 million, both modest relative to operating profit. However, the prior-year comparison contained less-repeatable support. Management specifically identifies a one-time foreign-exchange gain on conversion of an FX loan to equity and a waiver of markup on that loan in the first nine months of FY2025.

The company does not provide a clean amount for those prior-year one-offs in the current directors’ report, so a normalized PAT figure would be speculative. What the statements show is that nine-month other income fell about 51% to Rs50.7 million from Rs103.4 million. Part of the profit decline therefore reflects a tougher below-operating-profit comparison, while the deterioration in gross and operating margins is a separate recurring operational issue.

Reported EPS also requires care. The 55% fall from Rs3.41 to Rs1.53 looks much worse than the 6.1% fall in PAT because BFAGRO’s weighted-average share count more than doubled after shares issued through the IPO. The company explicitly flags this dilution effect. For operating analysis, PAT and margin movements are more informative than the headline EPS percentage change.

Cash flow, working capital and funding

Cash conversion weakened sharply. Operating profit before working-capital changes was Rs558.6 million, down 15.0% from Rs657.2 million. After working capital, taxes and finance costs, net cash generated from operating activities fell to Rs73.9 million from Rs422.4 million. Inventory increased heavily, trade payables fell and receivables also consumed cash.

Inventory rose to Rs788.7 million at 31 March from Rs447.3 million at June 2025, an increase of 76.3%. Trade debts increased to Rs1.310 billion from Rs1.269 billion, while trade and other payables fell to Rs192.9 million from Rs334.7 million. More cash was therefore tied up in stock while supplier financing declined. This can accompany a capacity ramp, but it raises the importance of inventory turns and collection discipline.

The expansion cycle is even clearer in investing cash flow. Capital expenditure reached Rs915.2 million in nine months versus Rs73.3 million a year earlier. Property, plant and equipment more than doubled to Rs1.688 billion. The company partly funded this by liquidating short-term investments: those investments fell to Rs244.1 million from Rs1.021 billion at June 2025, while the cash-flow statement records Rs777.4 million of short-term-investment inflows.

Debt also increased. Short-term borrowings rose to Rs575.2 million from Rs314.8 million at June 2025, and current liabilities increased to Rs779.3 million from Rs657.6 million. Static liquidity remains strong: current assets were Rs2.724 billion and the current ratio about 3.50x, though lower than 4.58x at June. The bigger question is whether the new capacity can convert the capital and working-capital build into operating cash.

Capacity expansion and strategic developments

Faisalabad is the most immediate operating catalyst. The IPO-funded pasteurized-egg plant moved through installation and commissioning during the March quarter. The separate IPO progress report showed 92.36% utilization of the allocated project budget by 31 March, while the directors’ report later stated the facility was operational. The next result should therefore begin to show whether new capacity adds volume efficiently or initially carries under-utilization costs.

BFAGRO is also building an egg-powder production unit in Karachi. Management says machinery orders have been placed, letters of credit established and construction is underway. Egg powder would broaden the product set beyond liquid pasteurized egg products, but the financial benefit should not be assumed before commissioning, utilization and customer uptake are disclosed.

Backward integration is another strategic leg. The company says a wholly owned layer farm is under development and it acquired a 26% stake in Agrolayer Protein Farms (Private) Limited on 19 January 2026 for a second poultry-farm project. The stated objective is supply stability and cost optimization. Successful integration could reduce exposure to volatile shell-egg procurement, but it also adds capital and execution demands; the March accounts do not yet show a material earnings contribution from the associate.

Sector and macro context

The wider export environment was difficult. PBS reported Pakistan’s total merchandise exports down 8.0% in US-dollar terms during July–March FY2026 and down 14.0% year on year in March alone. BFAGRO’s own export sales were almost flat over nine months, so the company performed better than the aggregate export trend, but the national data do not isolate egg products and should not be used as proof of BFAGRO-specific demand.

The March Middle East conflict also matters because BFAGRO sells into GCC markets and management says value-added egg-product exports were disrupted in March before resuming, while freight costs increased. SBP’s 9 March policy statement independently noted that the conflict had raised global fuel prices, freight and insurance costs and affected cross-border trade. This supports the existence of the macro shock, though the exact financial effect on BFAGRO remains unquantified.

After the reporting period, SBP raised the policy rate to 11.5% effective 28 April 2026 as Middle East energy, freight, insurance and supply-chain risks intensified. That change did not drive the March numbers, but it matters for the next cycle because BFAGRO entered it with higher short-term borrowings and a large capex program.

Historical pattern

BFAGRO’s multi-year pattern before FY2026 was one of rapid scaling: FY2025 revenue reached Rs7.247 billion versus Rs6.068 billion in FY2024 as the company expanded capacity and completed its IPO. March 2026 is a different phase. Sales are still growing, but gross and operating margins are no longer expanding, while post-IPO liquidity is being converted into plant, inventory and working capital. The payoff now has to appear in utilization, margins and cash generation.

What to monitor next

  • Faisalabad ramp-up: look for disclosed production volumes, capacity utilization and incremental sales from the newly commissioned plant rather than relying only on commissioning milestones.
  • Gross margin: test whether softer egg prices and new capacity can reverse the 64-basis-point nine-month margin decline without freight or overhead absorbing the benefit.
  • Inventory and cash conversion: inventory rose 76% from June and operating cash flow fell 82.5%; the next result should show whether this was expansion-related stocking or a persistent working-capital drag.
  • Short-term borrowing: debt rose as capex accelerated. Track whether operating cash generation begins to fund the expansion or reliance on short-term borrowing continues.
  • Export recovery: management says March disruption eased and demand resumed, but export sales were slightly lower over nine months. A return to growth would help mix and capacity absorption.
  • Egg-powder and poultry-farm execution: monitor project timing, capital commitments and evidence that backward integration improves raw-material stability rather than simply adding fixed assets.
  • Post-period interest and freight environment: the April policy-rate increase and continuing Middle East supply-chain risks raise the hurdle for a capex-heavy expansion story.

Bottom line

BFAGRO’s March 2026 result is a transition-quarter story rather than a simple earnings-growth story. Revenue continued to rise and the Q3 bottom line held up, but gross margin compressed, operating profit fell and nine-month PAT declined. Lower finance costs prevented a deeper earnings decline, while the prior-year comparison also contained one-off income that did not repeat.

At the same time, the company is moving from fundraising and construction into operation: the Faisalabad plant has been commissioned, project funds are largely deployed, and further egg-powder and poultry-farm investments are underway. The next result is therefore especially important. The question is no longer whether BFAGRO can deploy the IPO proceeds; it is whether the new asset base can deliver higher volumes, recover margins and restore cash conversion without requiring progressively more short-term funding.

Sources

Explore more research

All articles